These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33822446)

  • 1. Preinfection glycaemic control and disease severity among patients with type 2 diabetes and COVID-19: A retrospective, cohort study.
    Hayek S; Ben-Shlomo Y; Balicer R; Byrne K; Katz M; Kepten E; Raz I; Roitman E; Zychma M; Barda N
    Diabetes Obes Metab; 2021 Aug; 23(8):1995-2000. PubMed ID: 33822446
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of urgently initiated tele-prescription due to COVID-19 on glycemic control in patients with type 2 diabetes.
    Park SD; Kim NY; Jeon JH; Kim JG; Lee IK; Park KG; Choi YK
    Korean J Intern Med; 2021 Jul; 36(4):942-948. PubMed ID: 34092049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycemic control metrics using flash glucose monitoring and hospital complications in patients with COVID-19.
    Gómez AM; Henao DC; Muñoz OM; Aschner P; Yepes CA; Jojoa R; Kerguelen A; Parra D; Jaramillo P; Umpierrez GE
    Diabetes Metab Syndr; 2021; 15(2):499-503. PubMed ID: 33662836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Year-Long Trend in Glycated Hemoglobin Levels in Patients with Type 2 Diabetes during the COVID-19 Pandemic.
    Jin J; Lee SW; Lee WK; Jeon JH; Kim JG; Lee IK; Choi YK; Park KG
    Endocrinol Metab (Seoul); 2021 Oct; 36(5):1142-1146. PubMed ID: 34674507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 and diabetes: Insulin requirements parallel illness severity in critically unwell patients.
    Wu L; Girgis CM; Cheung NW
    Clin Endocrinol (Oxf); 2020 Oct; 93(4):390-393. PubMed ID: 32683745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin Use, Diabetes Control, and Outcomes in Patients with COVID-19.
    Riahi S; Sombra LRS; Lo KB; Chacko SR; Neto AGM; Azmaiparashvili Z; Patarroyo-Aponte G; Rangaswami J; Anastasopoulou C
    Endocr Res; 2021; 46(2):45-50. PubMed ID: 33275067
    [No Abstract]   [Full Text] [Related]  

  • 7. Glycaemic trajectory and predictors of suboptimal glycaemic control in people with type 2 diabetes.
    Pathiraja NP; Colman PG; Wentworth JM
    Intern Med J; 2020 Nov; 50(11):1415-1418. PubMed ID: 33215839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycaemic control in diabetes - Bridging the gap.
    Raizada N; Khadgawat R
    Indian J Med Res; 2020 Nov; 152(5):439-441. PubMed ID: 33707383
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical considerations in patients with diabetes during times of COVID19: An update on lifestyle factors and antihyperglycemic drugs with focus on India.
    Gupta R; Misra A
    Diabetes Metab Syndr; 2020; 14(6):1777-1781. PubMed ID: 32942253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of COVID-19 lockdown on glycemic control in type 1 diabetes.
    Duarte V; Mota B; Ferreira S; Costa C; Correia CC
    Arch Pediatr; 2022 Jan; 29(1):27-29. PubMed ID: 34955306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of glycemic control of type 2 diabetes between private hospital and governmental hospital.
    Al-Shaikh AA
    Saudi Med J; 2006 Mar; 27(3):424-6. PubMed ID: 16532119
    [No Abstract]   [Full Text] [Related]  

  • 12. Comment on short- and long-term prognosis of glycemic control in COVID-19 patients with type 2 diabetes.
    Chu WM; Wei JC
    QJM; 2022 Aug; 115(8):567-568. PubMed ID: 35678599
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of coronavirus disease 2019 pandemic on the lifestyle and glycemic control in patients with type 2 diabetes: a cross-section and retrospective cohort study.
    Munekawa C; Hosomi Y; Hashimoto Y; Okamura T; Takahashi F; Kawano R; Nakajima H; Osaka T; Okada H; Majima S; Senmaru T; Nakanishi N; Ushigome E; Hamaguchi M; Yamazaki M; Fukui M
    Endocr J; 2021 Feb; 68(2):201-210. PubMed ID: 32999133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes care during the acute phase of infection in ICU patients with specific attention to COVID-19 outbreak.
    Catargi B; Cheisson G; Tauveron I; Jacqueminet S; Benhamou D
    Anaesth Crit Care Pain Med; 2020 Jun; 39(3):375-379. PubMed ID: 32620420
    [No Abstract]   [Full Text] [Related]  

  • 15. Characteristics, treatment patterns, and glycemic control of older type 2 diabetes mellitus patients in China.
    Cai XL; Shen J; Ye BQ; Li Q; Clark DAS; Ji LN
    Chin Med J (Engl); 2021 Sep; 134(23):2893-2895. PubMed ID: 34406148
    [No Abstract]   [Full Text] [Related]  

  • 16. Weight change and glycemic control in type 2 diabetes patients during COVID-19 pandemic: the lockdown effect.
    Biamonte E; Pegoraro F; Carrone F; Facchi I; Favacchio G; Lania AG; Mazziotti G; Mirani M
    Endocrine; 2021 Jun; 72(3):604-610. PubMed ID: 33950348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of premixed insulin to achieve glycaemic control in type 2 diabetes: A retrospective UK cohort study.
    Jude EB; Trescoli C; Emral R; Ali A; Lubwama R; Palmer K; Shaunik A; Nanda N; Raskin P; Gomez-Peralta F
    Diabetes Obes Metab; 2021 Apr; 23(4):929-937. PubMed ID: 33319424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of glycemic control on the Diabetes Complications Severity Index score and development of complications in people with newly diagnosed type 2 diabetes.
    Pantalone KM; Misra-Hebert AD; Hobbs TM; Wells BJ; Kong SX; Chagin K; Dey T; Milinovich A; Weng W; Bauman JM; Burguera B; Zimmerman RS; Kattan MW
    J Diabetes; 2018 Mar; 10(3):192-199. PubMed ID: 28976724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of glycemic traits in susceptibility to COVID-19 risk: a Mendelian randomization study.
    Au Yeung SL; Zhao JV; Schooling CM
    BMC Med; 2021 Mar; 19(1):72. PubMed ID: 33757497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of COVID-19 Lockdown on Glycemic Control in Patients with Type 2 Diabetes Mellitus in Dubai.
    Makki I; Alnoon N; Rahmani N; Almulla J; Alamiri A; Alfalasi A; Zidan M
    Curr Diabetes Rev; 2022; 18(8):e081221198650. PubMed ID: 34879807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.